BTE vs PTEN

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability, and a concerning lack of Altman Z-Score data, which raises transparency and solvency concerns. Despite trading below its Graham Number of $4.22 at $3.32, the stock shows deteriorating fundamentals, including sharply negative earnings and revenue growth (YoY: -82.6% and -12.3%, respectively), weak profitability trends, and a deteriorating technical trend (10/100). While the dividend appears sustainable with a 32% payout ratio, the current ratio of 0.58 signals near-term liquidity pressure. The company's inconsistent earnings performance, with frequent large misses and volatility in surprises, undermines confidence in its operational predictability.

PTEN exhibits severe fundamental weakness, highlighted by a critical Piotroski F-Score of 2/9, indicating a deteriorating financial position. While the stock has seen a strong 1-year price increase, this is disconnected from operational reality: the company reports negative profit margins and an unsustainable dividend payout ratio of 213.33%. Bearish insider sentiment and negative revenue growth further undermine the bullish analyst consensus. The combination of operational inefficiency and capital mismanagement suggests a high risk of a price correction.